NCT02661178View on ClinicalTrials.gov

First in Man Clinical Trial of Emodepside (BAY 44-4400)

PHASE1CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 27, 2017

Study Completion Date

March 27, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

emodepside (BAY 44-4400)

DRUG

placebo

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Drugs for Neglected Diseases

OTHER